(232 days)
No
The device description and performance studies focus on the mechanical and material properties of the shoulder prosthesis components. There is no mention of AI, ML, image processing, or data analysis related to patient anatomy or surgical planning.
Yes
The device is a Reverse Shoulder Prosthesis, indicated for the treatment of humeral fractures and total shoulder replacement, which are medical conditions, and restores lost function.
No
Explanation: The device described is a shoulder prosthesis, an implant used for total shoulder replacement. It is designed for treatment and replacement, not for diagnosing a condition.
No
The device description clearly outlines multiple physical components made of materials like Ti alloy, intended for surgical implantation. This is a hardware medical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device for surgical implantation to replace a shoulder joint. This is a therapeutic and reconstructive purpose, not a diagnostic one.
- Device Description: The components listed are all parts of a prosthetic implant designed to be placed inside the body. IVDs are typically used to examine samples taken from the body (like blood, urine, or tissue) to diagnose conditions.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples, detecting biomarkers, or providing diagnostic information.
- Anatomical Site: The device is used in the shoulder joint, not to analyze samples from the shoulder joint.
- Performance Studies: The performance studies focus on the mechanical properties, wear, and stability of the implant, which are relevant to a surgical device, not a diagnostic one.
In summary, the device is a surgical implant for treating shoulder conditions, not a diagnostic tool used to analyze samples.
N/A
Intended Use / Indications for Use
The Reverse Shoulder Prosthesis is indicated for treatment of humeral fractures and for primary or revision total shoulder replacement in patients with a grossly deficient rotator cuff shoulder joint with severe arthropathy failed joint replacement and a grossly deficient rotator cuff shoulder joint.
The patient's joint must be anatomically suited to receive the selected implant(s), and a functional deltoid muscle is necessary for the device to offer full function in vivo.
The glenoid baseplate is intended for cementless application of screws for primary stability.
Product codes (comma separated list FDA assigned to the subject device)
PHX, HSD, MBF
Device Description
The Medacta Shoulder System is a modular system intended to be used for Reverse Shoulder Arthroplastises (RSA). The Medacta Shoulder System is composed of the following components:
- Humeral Diaphysis Cemented .
- Humeral Diaphysis - Cementless
- Humeral Reverse Metaphysis
- Humeral Reverse HC Liner (also referred to as PE Liner) ■
- Glenoid Baseplate
- Glenoidsphere
- Glenoid Polyaxial Locking Screws
- Reverse Metaphysis Screw
- Glenoidsphere Screw
The Humeral Diaphysis and Humeral Reverse Metaphysis are intended to be assembled together by means of a cylindrical driven-fit coupling and tightened by the Reverse Metaphysis Screw. The Humeral Reverse HC Liner is intended to be coupled by means of an embedded clipping mechanism with the Humeral Reverse Metaphysis.
The Glenoid Baseplate is intended to be fixed on the glenoid bone by means of a central press-fit and with the help of Glenoid Polyaxial Locking Screws. The Glenoidsphere is intended to be assembled with the Glenoid Baseplate by means of a taper Morse connection and secured by the Glenoidsphere Screw.
The Glenoidsphere Screw, Reverse Metaphysis Screw, and Glenoid Polyaxial Locking Screws are made of Ti alloy enhanced with Type-II anodization.
The Medacta Shoulder System is similar to the predicate devices DePuy Delta Xtend™ (K062250 and K071379), Biomet Comprehensive® RS Shoulder System (K072804) and Tornier Aequalis Reversed II (K112144).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Shoulder joint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Studies
- Characterization Tests
- Validation Cadaveric Workshop Evaluations
- ROM of the Medacta Shoulder System-RSA
- Humeral Diaphysis Assessment of Design and Dimensions
- Design Validation Report
- Performance Tests
- Wear Test: ASTM F1378-12: Standard Specification For Shoulder Prosthesis
- Fatigue Testing: ASTM F1378-12: Standard Specification For Shoulder Prosthesis
- Static Fatigue Testing: ASTM F1378-12: Standard Specification For Shoulder Prosthesis
- Micromotions Assessment In Reverse Configuration: ASTM F2028-14: Standards Test Methods For Dynamic Evaluation of Glenoid Loosening Or Disassociation Prostheses
- Static Fatigue Testing: ASTM F543-13: Standard Specification And Test Methods For Metallic Medical Bone Screws
- Coating Tests
- Humeral Reverse Metaphysis: ASTM F2024-10: Standard Practice For X-ray Diffraction Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
- Glenoid Baseplate: ASTM F2024-10: Standard Practice For X-ray Diffraction Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
- Humeral Diaphysis: ASTM F2024-10: Standard Practice For X-ray Diffraction Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
Pyrogenicity
- Medacta uses both the Bacterial Endotoxin Test (LAL test) according to European Pharmacopoeia §2.6.14 (which is equivalent to USP chapter ) and the Pyrogen Test according to USP chapter for pyrogenicity determination.
- Medacta has no intentions of labeling the subject devices as non-pyrogenic or pyrogen free.
Clinical Studies
- No clinical studies were conducted.
Key results: The information provided supports the Medacta Shoulder System is as safe and effective as the predicate devices. Therefore, it is concluded that the Medacta Shoulder System is substantially equivalent to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K062250, K071379, K072804, K083439, K112144
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3660 Shoulder joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II. The special controls for this device are:(1) FDA's:
(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”
(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”
(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and
(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”
(2) International Organization for Standardization's (ISO):
(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”
(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”
(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”
(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”
(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”
(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and
(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and
(3) American Society for Testing and Materials':
(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”
(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”
(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”
(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”
(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”
(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”
(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and
(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”
0
Image /page/0/Picture/0 description: The image shows the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration. The Department of Health & Human Services logo is on the left, and the U.S. Food & Drug Administration logo is on the right. The FDA logo is blue and white and includes the words "FDA U.S. FOOD & DRUG ADMINISTRATION".
Medacta International Sa % Elizabeth Rose Manager, Regulatory Affairs Mapi Usa. Inc. 2343 Alexandria Drive Suite 100 Lexington, Kentucky 40504
October 5, 2017
Re: K170452
Trade/Device Name: Medacta Shoulder System Regulation Number: 21 CFR 888.3660 Regulation Name: Shoulder Joint Metal/Polymer Semi-Constrained Cemented Prosthesis Regulatory Class: Class II Product Code: PHX, HSD, MBF Dated: September 7, 2017 Received: September 8, 2017
Dear Elizabeth Rose:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K170452
Device Name Medacta Shoulder System
Indications for Use (Describe)
The Reverse Shoulder Prosthesis is indicated for treatment of humeral fractures and for primary or revision total shoulder replacement in patients with a grossly deficient rotator cuff shoulder joint with severe arthropathy failed joint replacement and a grossly deficient rotator cuff shoulder joint.
The patient's joint must be anatomically suited to receive the selected implant(s), and a functional deltoid muscle is necessary for the device to offer full function in vivo.
The glenoid baseplate is intended for cementless application of screws for primary stability.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
3.0 510(k) Summary
I. Submitter
Medacta International SA Strada Regina 6874 Castel San Pietro (CH) Switzerland Phone (+41) 91 696 60 60 Fax (+41) 91 696 60 66
Contact Person: Stefano Baj, Regulatory Affairs Manager Date Prepared: February 14, 2017 Date Revised: September 07, 2017
| Device Proprietary Name: | Medacta Shoulder System |
|---|---|
| Common or Usual Name: | Shoulder Prosthesis, Reverse Configuratin |
| Classification Name: | Shoulder joint metal/polymer semi-constrained cemented |
| prosthesis. | |
| Primary Product Code: | PHX |
| Secondary Product Code: | HSD, MBF |
| Regulation Number: | 21 CFR 888.3660, 21 CFR 888.3690, 21CFR 888.3670 |
| Device Classification | 2 |
TT Device
III. Predicate Device
Substantial equivalence is claimed to the following devices: Primary Predicate:
- Delta Xtend™ Reverse Shoulder System, K062250, DePuy Orthopaedics, Inc. ●
- Delta Xtend™ Reverse Shoulder Modular Stem, K071379, DePuy Orthopaedics, Inc. ●
Additional Predicates
- Comprehensive® RS Shoulder System, K072804, Biomet Manufacturing Corporation ●
- Synthes Epoca Shoulder Prosthesis System, K083439, Synthes (USA) ●
- Aequalis Shoulder Fracture System & Aequalis Shoulder System, Aequalis Reversed Shoulder Prosthesis, Aequalis Reversed Fracture Shoulder Prosthesis (also referred to as Aequalis Reversed II), K112144, Tornier
Reference Device
- Versafitcup™ Double Mobility Highcross® HXUHMWPE Liners, K092265, Medacta ● International, SA
4
Medacta International SA
Medacta Shoulder System Traditional 510(k)
IV. Device Description
The purpose of this submission is to gain clearance for the new Medacta Shoulder System. The Medacta Shoulder System is a modular system intended to be used for Reverse Shoulder Arthroplastises (RSA). The Medacta Shoulder System is composed of the following components:
- Humeral Diaphysis Cemented .
- 트 Humeral Diaphysis - Cementless
- Humeral Reverse Metaphysis
- Humeral Reverse HC Liner (also referred to as PE Liner) ■
- Glenoid Baseplate
- Glenoidsphere
- Glenoid Polyaxial Locking Screws
- Reverse Metaphysis Screw
- Glenoidsphere Screw
The Humeral Diaphysis and Humeral Reverse Metaphysis are intended to be assembled together by means of a cylindrical driven-fit coupling and tightened by the Reverse Metaphysis Screw. The Humeral Reverse HC Liner is intended to be coupled by means of an embedded clipping mechanism with the Humeral Reverse Metaphysis.
The Glenoid Baseplate is intended to be fixed on the glenoid bone by means of a central press-fit and with the help of Glenoid Polyaxial Locking Screws. The Glenoidsphere is intended to be assembled with the Glenoid Baseplate by means of a taper Morse connection and secured by the Glenoidsphere Screw.
The Glenoidsphere Screw, Reverse Metaphysis Screw, and Glenoid Polyaxial Locking Screws are made of Ti alloy enhanced with Type-II anodization.
The Medacta Shoulder System is similar to the predicate devices DePuy Delta Xtend™ (K062250 and K071379), Biomet Comprehensive® RS Shoulder System (K072804) and Tornier Aequalis Reversed II (K112144).
V. Indications for Use
The Reverse Shoulder Prosthesis is indicated for treatment of humeral fractures and for primary or revision total shoulder replacement in patients with a grossly deficient rotator cuff shoulder joint with severe arthropathy or a previously failed joint replacement and a grossly rotator cuff deficient shoulder joint.
The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional deltoid muscle is necessary to use the device.
5
The glenoid baseplate is intended for cementless application with the addition of screws for fixation.
VI. Comparison of Technological Characteristics
The Medacta Shoulder System and the predicate devices share the following characteristics:
- indications for use;
- materials:
- design:
- sterile:
- coating;
- thread design; and ●
- device usage
The Medacta Shoulder System is technologically different from the predicate devices as follows:
- sizes:
- lengths; and ●
- diameters ●
Biocompatibility testing conducted on the predicate devices for the same or similar materials supports the biological safety of the Medacta Shoulder System. The Medacta Shoulder System components are manufactured from the following materials:
- Titanium Alloy (Ti6-A1 4-V) ISO 5832-3:1996 Implants For Surgery Metallic O Materials - Part 3: Wrought Titanium 6-Aluminum 4-Vanadium Alloy
- Titanium Alloy (Ti6-A1 7-Nb) ISO 5832-11 Second Edition 2014-09-15: Implants For O Surgery - Metallic Materials - Part 11: Wrought Titanium 6-Aluminium 7-Niobium Alloy
- Cobalt-Chromium-Molybdenum alloy (Co-Cr-Mo) per ISO 5832-12 Second Edition o 2007-05-01: Implants For Surgery-- Metallic Materials -- Part 12: Wrought Cobalt-Chromium-Molybdenum Alloy [Including: Technical Corrigedum 1 (2008)]
- Ultra High Molecular Weight Polyethylene (UHMWPE) Highcross O
These materials have an extensive amount of biocompatibility data that has been provided in the listed predicate devices' 510(k) submissions DePuy Delta Xtend™ (K062250 and K071379), Biomet Comprehensive® RS Shoulder System (K072804) and Tornier Aequalis Reversed II (K112144), as well as the UHMWPE Highcross reviewed in reference device Versafitcup™ Double Mobility Highcross® HXUHMWPE Liners (K092265).
The Titanium Y367 + Hydroxyapatite "Osprovit®" coating used on the Medacta Shoulder System - Humeral Diaphysis Cementless component is provided by Eurocoating S.p.A. The Hydroxyapatite "Osprovit®" coating used on the Medacta Shoulder System - Humeral Reverse Metaphysis and Glenoid Baseplate components is provided by Eurocoating S.p.A.
6
Additional biocompatibility testing was deemed unnecessary because the materials are the same or similar to the predicate devices and follow standards for manufacturing.
A comparison of the subject and predicate devices are provided in the table below.
| Parameters | Medacta
Shoulder System
(Subject Device) | DePuy Delta
Xtend™
K062250 and
K071379
(Predicate
Device) | Biomet
Comprehensive®
RS Shoulder
System K072804
(Predicate
Device) | Tornier
Aequalis
Reversed II
K112144
(Predicate
Device) |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Material | Titanium Alloy,
Cobalt
Chromium,
UHMWPE | Titanium Alloy,
Cobalt
Chromium,
UHMWPE | Titanium Alloy,
Cobalt
Chromium,
UHMWPE | Titanium Alloy,
Cobalt
Chromium,
UHMWPE |
| Coating | Titanium
(ASTM F1580)
Hydroxyapatite
(ASTM F1185) | Hydroxyapatite
(ASTM F1185) | Titanium
(ASTM F1580)
Hydroxyapatite
(ASTM F1185) | Titanium
(ASTM F1580)
Hydroxyapatite
(ASTM F1185) |
| Bone Cement | Cemented/
Cementless | Cemented/
Cementless | Cemented/
Cementless | Cemented/
Cementless |
| System
Components | STD Humeral
Diapyhsis
(Cementless/Cem
ented), Humeral
Reverse
Metaphysis,
Humeral Reverse
HC Liner,
Glenoid
Baseplate,
Glenoid Polyaxial
Locking Screw,
Glenoidsphere | STD Humeral
Diapyhsis
(Cementless/Cem
ented), Humeral
Reverse
Metaphysis,
Humeral Reverse
Liner, Glenoid
Baseplate,
Glenoid Polyaxial
Locking Screw,
Glenoidsphere | STD Humeral
Diapyhsis
(Cementless/Cem
ented), Humeral
Reverse
Metaphysis,
Humeral Reverse
Liner, Glenoid
Baseplate,
Glenoid Polyaxial
Locking Screw,
Glenoidsphere | STD Humeral
Diapyhsis
(Cementless/Cem
ented), Humeral
Reverse
Metaphysis,
Humeral Reverse
Liner, Glenoid
Baseplate,
Glenoid Polyaxial
Locking Screw,
Glenoidsphere |
| Device usage | Single Use | Single Use | Single Use | Single Use |
| Biocompatibility | Implant with
permanent >30
day
(Equivalency
determined) | Implant with
permanent >30
day | Implant with
permanent >30
day | Implant with
permanent >30
day |
| Sterilization | Gamma and EO | Gamma and EO | Gamma and EO | Gamma and EO |
Technological comparison
Discussion
As seen above, the technological differences between the subject and predicate devices do not raise new questions of safety and effectiveness. The Medacta Shoulder System is the same or
7
similar to the predicate devices in terms of intended use, materials of construction, design, coating, thread design, device usage, and sterility. Based on the comparison of technological characteristics and performance data provided within this submission, the data supports the substantial equivalence of the Medacta Shoulder System to the identified predicate devices.
VII. Performance Data
The following mechanical tests are being provided in support of a substantial equivalence determination. Based on the risk analysis and pre-submission submitted to review testing protocols, testing was conducted to written protocols with acceptance criteria that were based on standards.
Non-Clinical Studies
- Characterization Tests
- O Validation Cadaveric Workshop Evaluations
- ROM of the Medacta Shoulder System-RSA O
- Humeral Diaphysis Assessment of Design and Dimensions O
- Design Validation Report O
- Performance Tests
- O Wear Test: ASTM F1378-12: Standard Specification For Shoulder Prosthesis
- Fatigue Testing: ASTM F1378-12: Standard Specification For Shoulder O Prosthesis
- Static Fatigue Testing: ASTM F1378-12: Standard Specification For Shoulder O Prosthesis
- Micromotions Assessment In Reverse Configuration: ASTM F2028-14: Standards o Test Methods For Dynamic Evaluation of Glenoid Loosening Or Disassociation Prostheses
- Static Fatigue Testing: ASTM F543-13: Standard Specification And Test O Methods For Metallic Medical Bone Screws
- Coating Tests ●
- o Humeral Reverse Metaphysis: ASTM F2024-10: Standard Practice For X-ray Diffraction Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
- Glenoid Baseplate: ASTM F2024-10: Standard Practice For X-ray Diffraction O Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
- Humeral Diaphysis: ASTM F2024-10: Standard Practice For X-ray Diffraction o Determination Of Phase Content Of Plasma-Sprayed Hydroxyapatite Coatings
Pyrogenicity
- . Medacta uses both the Bacterial Endotoxin Test (LAL test) according to European Pharmacopoeia §2.6.14 (which is equivalent to USP chapter ) and the Pyrogen Test according to USP chapter for pyrogenicity determination.
- Medacta has no intentions of labeling the subject devices as non-pyrogenic or pyrogen free.
8
Medacta International SA
Medacta Shoulder System Traditional 510(k)
Clinical Studies
- No clinical studies were conducted. .
VIII. Conclusion
The information provided above supports the Medacta Shoulder System is as safe and effective as the predicate devices. Therefore, it is concluded that the Medacta Shoulder System is substantially equivalent to the predicate devices.
------------------------------This space intentionally left blank-------------------------------------------------